4//SEC Filing
Huff James Warren 4
Accession 0001209191-23-015713
CIK 0001358762other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:09 PM ET
Size
49.1 KB
Accession
0001209191-23-015713
Insider Transaction Report
Form 4
Huff James Warren
DirectorSee Remarks
Transactions
- Sale
Class A common stock
2023-03-02$87.61/sh−4,034$353,419→ 59,919 total - Sale
Class A common stock
2023-03-02$88.59/sh−12,826$1,136,255→ 47,093 total - Sale
Class A common stock
2023-03-02$89.49/sh−5,742$513,852→ 41,351 total - Sale
Class A common stock
2023-03-02$90.57/sh−4,623$418,705→ 36,728 total - Sale
Class A common stock
2023-03-02$91.12/sh−570$51,938→ 36,158 total - Conversion
Class B common stock
2023-03-01−75,000→ 212,903 total→ Class A common stock (75,000 underlying) - Conversion
Class A common stock
2023-03-01+75,000→ 111,158 total - Sale
Class A common stock
2023-03-02$81.49/sh−8,104$660,395→ 103,054 total - Sale
Class A common stock
2023-03-02$83.31/sh−9,660$804,775→ 81,262 total - Sale
Class A common stock
2023-03-02$84.33/sh−7,439$627,331→ 73,823 total - Sale
Class A common stock
2023-03-02$85.25/sh−6,395$545,174→ 67,428 total - Sale
Class A common stock
2023-03-02$86.44/sh−3,475$300,379→ 63,953 total - Sale
Class A common stock
2023-03-02$82.20/sh−12,132$997,250→ 90,922 total
Holdings
- 12,500(indirect: By The 2021 JWH GRAT)
Class A common stock
- 1,583(indirect: By Trust)
Class A common stock
- 1,583(indirect: By Trust)
Class A common stock
- 17,617(indirect: By Trust)
Class B common stock
→ Class A common stock (17,617 underlying) - 17,617(indirect: By Trust)
Class B common stock
→ Class A common stock (17,617 underlying) - 51,818
Employee Stock Option (right to buy)
Exercise: $11.00Exp: 2026-05-25→ Class B common stock (51,818 underlying) - 99,950
Employee Stock Option (right to buy)
Exercise: $22.57Exp: 2026-12-07→ Class B common stock (99,950 underlying) - 124,600
Employee Stock Option (right to buy)
Exercise: $24.75Exp: 2027-12-06→ Class B common stock (124,600 underlying) - 57,250
Employee Stock Option (right to buy)
Exercise: $55.73Exp: 2029-01-02→ Class B common stock (57,250 underlying) - 28,625
Employee Stock Option (right to buy)
Exercise: $55.73Exp: 2029-01-02→ Class B common stock (28,625 underlying) - 28,625
Employee Stock Option (right to buy)
Exercise: $55.73Exp: 2029-01-02→ Class B common stock (28,625 underlying) - 20,133
Employee Stock Option (right to buy)
Exercise: $207.20Exp: 2030-01-02→ Class B common stock (20,133 underlying) - 23,968
Employee Stock Option (right to buy)
Exercise: $121.29Exp: 2031-01-04→ Class A common stock (23,968 underlying) - 146,824
Employee Stock Option (right-to-buy)
Exercise: $36.71Exp: 2033-01-03→ Class A common stock (146,824 underlying)
Footnotes (22)
- [F1]The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $88.10 to $89.09. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $89.11 to $90.105. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $90.11 to $91.10. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F13]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $91.12 to $91.14. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F14]The options vested in sixteen equal quarterly installments beginning on August 25, 2016.
- [F15]The options vested in twenty equal quarterly installments beginning on March 7, 2017, subject to continued service through each vesting date.
- [F16]The options vested in sixteen equal quarterly installments beginning on March 6, 2018, subject to continued service through each vesting date.
- [F17]The options vested in sixteen equal quarterly installments beginning on April 2, 2019, subject to continued service through each vesting date.
- [F18]On October 14, 2019, based on the satisfaction of certain performance criteria, the option vested as to 7,156 shares and the option was set to vest as to 21,469 shares in twelve equal quarterly installments beginning on January 14, 2020, subject to continued service through each vesting date. This vesting schedule has been updated to reflect the transfer of options to the reporting person's ex-spouse as described in footnote 2 above.
- [F19]On November 11, 2019, based on the satisfaction of certain performance criteria, the option vested as to 7,156 shares and the option was set to vest as to 21,469 shares in twelve equal quarterly installments beginning on February 11, 2020, subject to continued service through each vesting date. This vesting schedule has been updated to reflect the transfer of options to the reporting person's ex-spouse as described in footnote 2 above.
- [F2]Since the date of the reporting person's last ownership report, he transferred 287,903 shares of Class B common stock, and employee stock options to purchase 410,735 shares of Class B common stock, options to purchase 64,758 shares of Class A common stock and RSUs to purchase 10,867 shares of Class A common stock to his ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse.
- [F20]The options vest in sixteen equal quarterly installments beginning on April 2, 2020, subject to continued service through each vesting date.
- [F21]The options vest in sixteen equal quarterly installments beginning on April 4, 2021, subject to continued service through each vesting date.
- [F22]The options vest 1/16th of each grant on March 6, May 15, August 15, and November 15 of each year, subject to continued service through each vesting date.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $80.85 to $81.84. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $81.86 to $82.85. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $82.87 to $83.86. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $83.89 to $84.87. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $84.90 to $85.70. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $86.01 to $87.00. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $87.02 to $88.00. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeother
Related Parties
1- filerCIK 0001662411
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 5:09 PM ET
- Size
- 49.1 KB